Nat. Rev. Cardiol. doi: /nrcardio

Slides:



Advertisements
Similar presentations
Circulation Research Feb 3, 2012 Journal Club [Part 1] NR4A1 (Nur77) Deletion Polarizes Macrophages Toward an Inflammatory Phenotype and Increases Atherosclerosis.
Advertisements

Lipids, Lipoproteins and Aging
Lipoprotein Metabolism And Disorders
Metabolism of VLDL Dr. Nikhat Siddiqi.
Lipids, Lipoproteins and Atherosclerosis: Implications in Aging Trudy M Forte, PhD Lawrence Berkeley National Laboratory Children’s Hospital Oakland Research.
Lipoprotein Structures, Function and Metabolism (1)
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Inflammation and atherosclerosis Immune cells dominate early lesions Immune effector molecules accelerate lesion progression Activation of inflammation.
بسم الله الرحمن الرحيم.
Lipid Homeostasis and Transport CH353 February 12, 2008.
Lipoprotein Structure and Function LP core Triglycerides Cholesterol esters LP surface Phospholipids Proteins Cholesterol Are conjugated proteins, composed.
Metabolism - Session 5, Lecture 1 Lipid metabolism and Transport Suggested reading: Marks’ Essentials of Medical Biochemistry, Chapter 30, Chapter 31,
Lipids in the diet are hydrolyzed in the small intestine, and the resultant fatty acids and monoglycerides are repackaged with apoB-48 into TG-enriched.
Lipoproteins and Atheroscloresis
Lipoproteins and Atheroscloresis
Is atherosclerosis a metabolic disease?
بسم الله الرحمن الرحيم.
Interrupting bile-acid handling and lipid and glucose control: Effects of colesevelam on glucose levels  Michael H. Davidson, MD  Journal of Clinical.
LIPOPROTEINS A to Z.
Is atherosclerosis a metabolic disease?
Plasma Lipid Transport Role of HDL
HDL and Atherosclerosis
Paul Durrington  Atherosclerosis Supplements 
Figure 6 Cholesterol metabolism in obesity-related glomerulopathy
Figure 3 Neutrophils in liver inflammation
Figure 2 Hepatic action of functional foods and supplements
Volume 17, Issue 6, Pages (June 2013)
SMAD About Hepatitis C Virus Cell Entry and Liver Disease
Figure 1 Overview of lipoprotein metabolism and effects of novel lipid-modulating approaches Figure 1 | Overview of lipoprotein metabolism and effects.
Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency  Don P. Wilson, MD, FNLA, Mark Friedman,
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
CLA-1/SR-BI protein may promote cholesterol removal from peripheral cells Figure 84 The CLA-1 receptor is the human homolog of the SR-I receptor in mice.
Figure 4 Acute-phase HDL
Ezetimibe Blocks Internalization of the NPC1L1/Cholesterol Complex
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Innate immune responses in atherosclerosis
Roles for Chemokines in Liver Disease
Advanced Nutrition Lipids 5 MargiAnne Isaia, MD MPH.
Volume 7, Issue 5, Pages (May 2008)
Figure 4 Macrophages in liver inflammation
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Nephrol. doi: /nrneph
A Nuclear Strike against Listeria— The Evolving Life of LXR
Guido T. Bommer, Ormond A. MacDougald  Cell Metabolism 
Copyright © 2016 Elsevier Inc. All rights reserved.
Scavenger Receptor B-1 Emerges as Anti-atherogenic Candidate
Figure 2 Microbiota-related pathways in atherosclerosis
Lipid core constitution Activated macrophages accumulate lipids
Daniel J. Rader, Ellen Puré  Cell Metabolism 
Volume 7, Issue 5, Pages (May 2008)
Figure 2 GM-CSF — a key player in inflammation and autoimmunity
Anti-inflammatory Agents: Present and Future
Figure 3 Regulation of insulin sensitivity by innate immune cells
Figure 1 The major pathways of lipid metabolism
Daniel J. Rader, Ellen Puré  Cell Metabolism 
Monocyte-Macrophages and T Cells in Atherosclerosis
Volume 76, Issue 4, Pages (August 2009)
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Blood–brain barrier breakdown promotes neurodegeneration
Figure 3 Underlying mechanisms of TREG cells in atherosclerosis
Figure 2 Protective functions of HDL
Potential Mechanisms of Adverse Outcomes Associated with Torcetrapib
Figure 4 Role of chemokines in dendritic cell migration
Lipoproteins   Macromolecular complexes in the blood that transport lipids Apolipoproteins   Proteins on the surface of lipoproteins; they play critical.
Macrophages in the Pathogenesis of Atherosclerosis
Reverse cholesterol transport CETP is key in remodeling of HDL
Figure 1 Monocyte and macrophage ontogeny
Sander Lefere, Frank Tacke  JHEP Reports 
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
Presentation transcript:

Nat. Rev. Cardiol. doi:10.1038/nrcardio.2017.34 Figure 2 Effect of dyslipidaemia on monocyte recruitment, migration, and cell behaviour Figure 2 | Effect of dyslipidaemia on monocyte recruitment, migration, and cell behaviour. a | Hypercholesterolaemia promotes production of classical monocytes (defined in mice as lymphocyte antigen 6C (LY6C)high) by inducing proliferation of bone marrow precursors, which in turn leads to blood monocytosis, endothelial dysfunction, and increased recruitment mediated by chemokine receptor signals such as C-C chemokine receptor type 5 (CCR5)80,251, and ultimately leads to increased tissue monocyte-derived macrophages. Hypertriglyceridaemia increases accumulation of patrolling nonclassical monocytes (LY6Clow) and extravasation, possibly mediated by C-C motif chemokine 4 (CCL4)63. Dyslipidaemia might lead to increased proliferation of tissue-resident macrophages. Monocytes can endocytose circulating lipids, leading to formation of 'foamy' monocytes, which might then deliver lipids from the blood to peripheral tissues, contributing to increased lipid retention in tissues (via heparin sulfate proteoglycans; HSPGs) and to increased lipid endocytosis by tissue macrophages, promoting foam cell formation. Red lines indicate pathways upregulated in dyslipidaemia. Dotted lines represent hypothesized or unknown pathways. b | Lipids can enter the cell via regulated uptake, mediated for example by LDL receptor (LDLR) and LDLR-related protein 1 (LRP1), or via unregulated uptake, mediated among others by scavenger receptors such as CD36 and SRA1, and by Toll-like receptors (TLRs). Neutral lipids and cholesterol can then accumulate inside the cell, leading to proinflammatory or anti-inflammatory responses depending on the lipid species and lipid modification. Lipid entry also leads to activation of intracellular cholesterol storage and efflux pathways (reverse cholesterol transport). Increased lipid loading modulates the cytoskeleton by blocking signalling components such as RAS homologue gene family member A (RHOA), leading to defects in migration and possible tissue retention of macrophages62. ABCA1, ATP-binding cassette transporter subfamily A member 1; ABCG1, ATP-binding cassette transporter subfamily G member 1; CXCL16, C-X-C motif chemokine 16; LOX1, lectin-type oxidized LDL receptor 1; LPL, lipoprotein lipase; LXR, liver X receptor; mmLDL, minimally modified LDL; oxLDL, oxidized LDL; NEFA, nonesterified fatty acid; RXR, retinoid X receptor; TG, triglycerides; TGRL, triglyceride-rich lipoprotein; VLDL, very low-density lipoprotein. Mohammed Shamim Rahman et al. (2017) Effects of dyslipidaemia on monocyte production and function in cardiovascular disease Nat. Rev. Cardiol. doi:10.1038/nrcardio.2017.34